L Gustafsson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L Gustafsson

Showing results (381-390 of 386) with videos related to

Pageof 39

Sort By:

You have reached the last page of results.This site can display upto 386 results.

Frontiers in Pharmacology|June 25, 2014

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.

Expert Review of Clinical Pharmacology|December 10, 2014

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.

BMC Medicine|August 15, 2013

Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.

Frontiers in Pharmacology|May 30, 2013

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugsRickard E Malmström, Brian B Godman, Eduard Diogene, et al.

Physical Review Letters|March 5, 2009

Double-pionic fusion of nuclear systems and the "ABC" effect: approaching a puzzle by exclusive and kinematically complete measurementsM Bashkanov, C Bargholtz, M Berłowski, et al.

Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.

Pageof 39

Search research articles

Showing results (381-390 of 386) with videos related to

Sort By:

Pageof 39

You have reached the last page of results.This site can display upto 386 results.

Frontiers in Pharmacology|June 25, 2014

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.

Expert Review of Clinical Pharmacology|December 10, 2014

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.

BMC Medicine|August 15, 2013

Personalizing health care: feasibility and future implicationsBrian Godman, Alexander E Finlayson, Parneet K Cheema, et al.

Frontiers in Pharmacology|May 30, 2013

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugsRickard E Malmström, Brian B Godman, Eduard Diogene, et al.

Physical Review Letters|March 5, 2009

Double-pionic fusion of nuclear systems and the "ABC" effect: approaching a puzzle by exclusive and kinematically complete measurementsM Bashkanov, C Bargholtz, M Berłowski, et al.

Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.

Pageof 39